nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT2B15—Ezetimibe—atherosclerosis	0.168	0.215	CbGbCtD
Morphine—UGT1A3—Ezetimibe—atherosclerosis	0.0727	0.0929	CbGbCtD
Morphine—UGT1A3—Simvastatin—atherosclerosis	0.0676	0.0864	CbGbCtD
Morphine—UGT1A3—Lovastatin—atherosclerosis	0.0662	0.0845	CbGbCtD
Morphine—UGT2B7—Ezetimibe—atherosclerosis	0.0526	0.0672	CbGbCtD
Morphine—UGT2B7—Simvastatin—atherosclerosis	0.0489	0.0625	CbGbCtD
Morphine—UGT2B7—Lovastatin—atherosclerosis	0.0478	0.0611	CbGbCtD
Morphine—UGT1A1—Ezetimibe—atherosclerosis	0.0454	0.0581	CbGbCtD
Morphine—UGT1A1—Simvastatin—atherosclerosis	0.0422	0.054	CbGbCtD
Morphine—UGT1A1—Lovastatin—atherosclerosis	0.0413	0.0528	CbGbCtD
Morphine—CYP2C8—Simvastatin—atherosclerosis	0.0124	0.0158	CbGbCtD
Morphine—CYP2C8—Pravastatin—atherosclerosis	0.0121	0.0155	CbGbCtD
Morphine—CYP2C8—Lovastatin—atherosclerosis	0.0121	0.0155	CbGbCtD
Morphine—CYP2D6—Niacin—atherosclerosis	0.00999	0.0128	CbGbCtD
Morphine—ABCB1—Ezetimibe—atherosclerosis	0.00901	0.0115	CbGbCtD
Morphine—ABCB1—Simvastatin—atherosclerosis	0.00838	0.0107	CbGbCtD
Morphine—ABCB1—Lovastatin—atherosclerosis	0.0082	0.0105	CbGbCtD
Morphine—ABCB1—Pravastatin—atherosclerosis	0.0082	0.0105	CbGbCtD
Morphine—CYP2D6—Simvastatin—atherosclerosis	0.00789	0.0101	CbGbCtD
Morphine—CYP2D6—Pravastatin—atherosclerosis	0.00772	0.00987	CbGbCtD
Morphine—CYP2D6—Lovastatin—atherosclerosis	0.00772	0.00987	CbGbCtD
Morphine—CYP3A4—Ezetimibe—atherosclerosis	0.0054	0.0069	CbGbCtD
Morphine—CYP3A4—Rosuvastatin—atherosclerosis	0.0054	0.0069	CbGbCtD
Morphine—CYP3A4—Simvastatin—atherosclerosis	0.00502	0.00641	CbGbCtD
Morphine—CYP3A4—Pravastatin—atherosclerosis	0.00491	0.00628	CbGbCtD
Morphine—CYP3A4—Lovastatin—atherosclerosis	0.00491	0.00628	CbGbCtD
Morphine—Naloxone—TLR4—atherosclerosis	0.00147	0.711	CrCbGaD
Morphine—Naloxone—ESR1—atherosclerosis	0.000412	0.2	CrCbGaD
Morphine—Mental disorder—Simvastatin—atherosclerosis	0.000278	0.00212	CcSEcCtD
Morphine—Tremor—Lovastatin—atherosclerosis	0.000277	0.00211	CcSEcCtD
Morphine—Visual impairment—Pravastatin—atherosclerosis	0.000277	0.00211	CcSEcCtD
Morphine—Erythema—Simvastatin—atherosclerosis	0.000277	0.00211	CcSEcCtD
Morphine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000274	0.00209	CcSEcCtD
Morphine—Eye disorder—Niacin—atherosclerosis	0.000273	0.00208	CcSEcCtD
Morphine—Flatulence—Simvastatin—atherosclerosis	0.000273	0.00208	CcSEcCtD
Morphine—Dysgeusia—Simvastatin—atherosclerosis	0.000271	0.00207	CcSEcCtD
Morphine—Flushing—Niacin—atherosclerosis	0.000271	0.00207	CcSEcCtD
Morphine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000269	0.00205	CcSEcCtD
Morphine—Anaemia—Ezetimibe—atherosclerosis	0.000268	0.00204	CcSEcCtD
Morphine—Malaise—Lovastatin—atherosclerosis	0.000267	0.00203	CcSEcCtD
Morphine—Flushing—Pravastatin—atherosclerosis	0.000267	0.00203	CcSEcCtD
Morphine—Muscle spasms—Simvastatin—atherosclerosis	0.000266	0.00203	CcSEcCtD
Morphine—Vertigo—Lovastatin—atherosclerosis	0.000266	0.00203	CcSEcCtD
Morphine—Angiopathy—Niacin—atherosclerosis	0.000265	0.00202	CcSEcCtD
Morphine—Leukopenia—Lovastatin—atherosclerosis	0.000265	0.00202	CcSEcCtD
Morphine—Chills—Niacin—atherosclerosis	0.000262	0.002	CcSEcCtD
Morphine—Malaise—Ezetimibe—atherosclerosis	0.000262	0.002	CcSEcCtD
Morphine—Vision blurred—Simvastatin—atherosclerosis	0.000261	0.00199	CcSEcCtD
Morphine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000259	0.00198	CcSEcCtD
Morphine—Tremor—Simvastatin—atherosclerosis	0.000259	0.00198	CcSEcCtD
Morphine—Chills—Pravastatin—atherosclerosis	0.000258	0.00197	CcSEcCtD
Morphine—Insomnia—Rosuvastatin—atherosclerosis	0.000258	0.00196	CcSEcCtD
Morphine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000257	0.00196	CcSEcCtD
Morphine—Palpitations—Ezetimibe—atherosclerosis	0.000256	0.00196	CcSEcCtD
Morphine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000256	0.00195	CcSEcCtD
Morphine—Anaemia—Simvastatin—atherosclerosis	0.000256	0.00195	CcSEcCtD
Morphine—Malnutrition—Niacin—atherosclerosis	0.000254	0.00194	CcSEcCtD
Morphine—Erythema—Niacin—atherosclerosis	0.000254	0.00194	CcSEcCtD
Morphine—Cough—Ezetimibe—atherosclerosis	0.000253	0.00193	CcSEcCtD
Morphine—Chest pain—Lovastatin—atherosclerosis	0.000252	0.00192	CcSEcCtD
Morphine—Arthralgia—Lovastatin—atherosclerosis	0.000252	0.00192	CcSEcCtD
Morphine—Anxiety—Lovastatin—atherosclerosis	0.000251	0.00191	CcSEcCtD
Morphine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000251	0.00191	CcSEcCtD
Morphine—Hypertension—Ezetimibe—atherosclerosis	0.00025	0.00191	CcSEcCtD
Morphine—Flatulence—Niacin—atherosclerosis	0.00025	0.00191	CcSEcCtD
Morphine—Malaise—Simvastatin—atherosclerosis	0.000249	0.0019	CcSEcCtD
Morphine—Tension—Niacin—atherosclerosis	0.000249	0.0019	CcSEcCtD
Morphine—Discomfort—Lovastatin—atherosclerosis	0.000249	0.0019	CcSEcCtD
Morphine—Vertigo—Simvastatin—atherosclerosis	0.000249	0.0019	CcSEcCtD
Morphine—Leukopenia—Simvastatin—atherosclerosis	0.000248	0.00189	CcSEcCtD
Morphine—Arthralgia—Ezetimibe—atherosclerosis	0.000247	0.00188	CcSEcCtD
Morphine—Chest pain—Ezetimibe—atherosclerosis	0.000247	0.00188	CcSEcCtD
Morphine—Nervousness—Niacin—atherosclerosis	0.000247	0.00188	CcSEcCtD
Morphine—Flatulence—Pravastatin—atherosclerosis	0.000246	0.00188	CcSEcCtD
Morphine—Dry mouth—Lovastatin—atherosclerosis	0.000246	0.00188	CcSEcCtD
Morphine—Tension—Pravastatin—atherosclerosis	0.000245	0.00187	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000245	0.00187	CcSEcCtD
Morphine—Dysgeusia—Pravastatin—atherosclerosis	0.000245	0.00187	CcSEcCtD
Morphine—Muscle spasms—Niacin—atherosclerosis	0.000244	0.00186	CcSEcCtD
Morphine—Discomfort—Ezetimibe—atherosclerosis	0.000244	0.00186	CcSEcCtD
Morphine—Pain—Rosuvastatin—atherosclerosis	0.000244	0.00186	CcSEcCtD
Morphine—Constipation—Rosuvastatin—atherosclerosis	0.000244	0.00186	CcSEcCtD
Morphine—Confusional state—Lovastatin—atherosclerosis	0.000243	0.00186	CcSEcCtD
Morphine—Nervousness—Pravastatin—atherosclerosis	0.000243	0.00185	CcSEcCtD
Morphine—Dry mouth—Ezetimibe—atherosclerosis	0.000242	0.00184	CcSEcCtD
Morphine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000241	0.00184	CcSEcCtD
Morphine—Muscle spasms—Pravastatin—atherosclerosis	0.00024	0.00183	CcSEcCtD
Morphine—Infection—Lovastatin—atherosclerosis	0.00024	0.00183	CcSEcCtD
Morphine—Vision blurred—Niacin—atherosclerosis	0.000239	0.00183	CcSEcCtD
Morphine—Confusional state—Ezetimibe—atherosclerosis	0.000239	0.00182	CcSEcCtD
Morphine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000237	0.00181	CcSEcCtD
Morphine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000236	0.0018	CcSEcCtD
Morphine—Vision blurred—Pravastatin—atherosclerosis	0.000236	0.0018	CcSEcCtD
Morphine—Arthralgia—Simvastatin—atherosclerosis	0.000236	0.0018	CcSEcCtD
Morphine—Chest pain—Simvastatin—atherosclerosis	0.000236	0.0018	CcSEcCtD
Morphine—Infection—Ezetimibe—atherosclerosis	0.000235	0.00179	CcSEcCtD
Morphine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000235	0.00179	CcSEcCtD
Morphine—Anxiety—Simvastatin—atherosclerosis	0.000235	0.00179	CcSEcCtD
Morphine—Tremor—Pravastatin—atherosclerosis	0.000234	0.00179	CcSEcCtD
Morphine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000233	0.00178	CcSEcCtD
Morphine—Discomfort—Simvastatin—atherosclerosis	0.000233	0.00177	CcSEcCtD
Morphine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000232	0.00177	CcSEcCtD
Morphine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000232	0.00177	CcSEcCtD
Morphine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000232	0.00177	CcSEcCtD
Morphine—Anaemia—Pravastatin—atherosclerosis	0.000231	0.00176	CcSEcCtD
Morphine—Anorexia—Lovastatin—atherosclerosis	0.00023	0.00175	CcSEcCtD
Morphine—Skin disorder—Ezetimibe—atherosclerosis	0.00023	0.00175	CcSEcCtD
Morphine—Vertigo—Niacin—atherosclerosis	0.000228	0.00174	CcSEcCtD
Morphine—Syncope—Niacin—atherosclerosis	0.000228	0.00174	CcSEcCtD
Morphine—Confusional state—Simvastatin—atherosclerosis	0.000228	0.00174	CcSEcCtD
Morphine—Leukopenia—Niacin—atherosclerosis	0.000227	0.00173	CcSEcCtD
Morphine—Urticaria—Rosuvastatin—atherosclerosis	0.000226	0.00173	CcSEcCtD
Morphine—Oedema—Simvastatin—atherosclerosis	0.000226	0.00172	CcSEcCtD
Morphine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000226	0.00172	CcSEcCtD
Morphine—Malaise—Pravastatin—atherosclerosis	0.000226	0.00172	CcSEcCtD
Morphine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000225	0.00172	CcSEcCtD
Morphine—Vertigo—Pravastatin—atherosclerosis	0.000225	0.00171	CcSEcCtD
Morphine—Palpitations—Niacin—atherosclerosis	0.000224	0.00171	CcSEcCtD
Morphine—Infection—Simvastatin—atherosclerosis	0.000224	0.00171	CcSEcCtD
Morphine—Leukopenia—Pravastatin—atherosclerosis	0.000224	0.00171	CcSEcCtD
Morphine—Loss of consciousness—Niacin—atherosclerosis	0.000223	0.0017	CcSEcCtD
Morphine—Cough—Niacin—atherosclerosis	0.000222	0.00169	CcSEcCtD
Morphine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000221	0.00169	CcSEcCtD
Morphine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00022	0.00168	CcSEcCtD
Morphine—Insomnia—Lovastatin—atherosclerosis	0.000218	0.00167	CcSEcCtD
Morphine—Cough—Pravastatin—atherosclerosis	0.000218	0.00166	CcSEcCtD
Morphine—Paraesthesia—Lovastatin—atherosclerosis	0.000217	0.00165	CcSEcCtD
Morphine—Arthralgia—Niacin—atherosclerosis	0.000216	0.00165	CcSEcCtD
Morphine—Hypertension—Pravastatin—atherosclerosis	0.000216	0.00165	CcSEcCtD
Morphine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000216	0.00165	CcSEcCtD
Morphine—Anorexia—Simvastatin—atherosclerosis	0.000215	0.00164	CcSEcCtD
Morphine—Dyspnoea—Lovastatin—atherosclerosis	0.000215	0.00164	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000215	0.00164	CcSEcCtD
Morphine—Insomnia—Ezetimibe—atherosclerosis	0.000214	0.00163	CcSEcCtD
Morphine—Arthralgia—Pravastatin—atherosclerosis	0.000213	0.00162	CcSEcCtD
Morphine—Chest pain—Pravastatin—atherosclerosis	0.000213	0.00162	CcSEcCtD
Morphine—Paraesthesia—Ezetimibe—atherosclerosis	0.000213	0.00162	CcSEcCtD
Morphine—Dyspepsia—Lovastatin—atherosclerosis	0.000212	0.00162	CcSEcCtD
Morphine—Anxiety—Pravastatin—atherosclerosis	0.000212	0.00162	CcSEcCtD
Morphine—Dry mouth—Niacin—atherosclerosis	0.000211	0.00161	CcSEcCtD
Morphine—Dyspnoea—Ezetimibe—atherosclerosis	0.000211	0.00161	CcSEcCtD
Morphine—Discomfort—Pravastatin—atherosclerosis	0.00021	0.0016	CcSEcCtD
Morphine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00021	0.0016	CcSEcCtD
Morphine—Decreased appetite—Lovastatin—atherosclerosis	0.00021	0.0016	CcSEcCtD
Morphine—Dyspepsia—Ezetimibe—atherosclerosis	0.000208	0.00159	CcSEcCtD
Morphine—Fatigue—Lovastatin—atherosclerosis	0.000208	0.00159	CcSEcCtD
Morphine—Anaphylactic shock—Niacin—atherosclerosis	0.000207	0.00158	CcSEcCtD
Morphine—Oedema—Niacin—atherosclerosis	0.000207	0.00158	CcSEcCtD
Morphine—Pain—Lovastatin—atherosclerosis	0.000206	0.00157	CcSEcCtD
Morphine—Constipation—Lovastatin—atherosclerosis	0.000206	0.00157	CcSEcCtD
Morphine—Confusional state—Pravastatin—atherosclerosis	0.000206	0.00157	CcSEcCtD
Morphine—Decreased appetite—Ezetimibe—atherosclerosis	0.000206	0.00157	CcSEcCtD
Morphine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000206	0.00157	CcSEcCtD
Morphine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000204	0.00156	CcSEcCtD
Morphine—Asthenia—Rosuvastatin—atherosclerosis	0.000204	0.00156	CcSEcCtD
Morphine—Insomnia—Simvastatin—atherosclerosis	0.000204	0.00156	CcSEcCtD
Morphine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000204	0.00156	CcSEcCtD
Morphine—Oedema—Pravastatin—atherosclerosis	0.000204	0.00156	CcSEcCtD
Morphine—Fatigue—Ezetimibe—atherosclerosis	0.000204	0.00156	CcSEcCtD
Morphine—Shock—Niacin—atherosclerosis	0.000204	0.00156	CcSEcCtD
Morphine—Infection—Pravastatin—atherosclerosis	0.000203	0.00155	CcSEcCtD
Morphine—Paraesthesia—Simvastatin—atherosclerosis	0.000203	0.00155	CcSEcCtD
Morphine—Pain—Ezetimibe—atherosclerosis	0.000202	0.00154	CcSEcCtD
Morphine—Constipation—Ezetimibe—atherosclerosis	0.000202	0.00154	CcSEcCtD
Morphine—Tachycardia—Niacin—atherosclerosis	0.000202	0.00154	CcSEcCtD
Morphine—Pruritus—Rosuvastatin—atherosclerosis	0.000202	0.00154	CcSEcCtD
Morphine—Skin disorder—Niacin—atherosclerosis	0.000201	0.00154	CcSEcCtD
Morphine—Dyspnoea—Simvastatin—atherosclerosis	0.000201	0.00154	CcSEcCtD
Morphine—Hyperhidrosis—Niacin—atherosclerosis	0.0002	0.00153	CcSEcCtD
Morphine—Thrombocytopenia—Pravastatin—atherosclerosis	0.0002	0.00152	CcSEcCtD
Morphine—Feeling abnormal—Lovastatin—atherosclerosis	0.000199	0.00152	CcSEcCtD
Morphine—Dyspepsia—Simvastatin—atherosclerosis	0.000199	0.00152	CcSEcCtD
Morphine—Anorexia—Niacin—atherosclerosis	0.000198	0.00151	CcSEcCtD
Morphine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000197	0.00151	CcSEcCtD
Morphine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000197	0.00151	CcSEcCtD
Morphine—Decreased appetite—Simvastatin—atherosclerosis	0.000196	0.0015	CcSEcCtD
Morphine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000195	0.00149	CcSEcCtD
Morphine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000195	0.00149	CcSEcCtD
Morphine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000195	0.00149	CcSEcCtD
Morphine—Fatigue—Simvastatin—atherosclerosis	0.000195	0.00148	CcSEcCtD
Morphine—Anorexia—Pravastatin—atherosclerosis	0.000195	0.00148	CcSEcCtD
Morphine—Hypotension—Niacin—atherosclerosis	0.000194	0.00148	CcSEcCtD
Morphine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000194	0.00148	CcSEcCtD
Morphine—Pain—Simvastatin—atherosclerosis	0.000193	0.00147	CcSEcCtD
Morphine—Constipation—Simvastatin—atherosclerosis	0.000193	0.00147	CcSEcCtD
Morphine—Urticaria—Lovastatin—atherosclerosis	0.000192	0.00146	CcSEcCtD
Morphine—Abdominal pain—Lovastatin—atherosclerosis	0.000191	0.00146	CcSEcCtD
Morphine—Body temperature increased—Lovastatin—atherosclerosis	0.000191	0.00146	CcSEcCtD
Morphine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000189	0.00144	CcSEcCtD
Morphine—Dizziness—Rosuvastatin—atherosclerosis	0.000188	0.00144	CcSEcCtD
Morphine—Urticaria—Ezetimibe—atherosclerosis	0.000188	0.00143	CcSEcCtD
Morphine—Insomnia—Niacin—atherosclerosis	0.000187	0.00143	CcSEcCtD
Morphine—Abdominal pain—Ezetimibe—atherosclerosis	0.000187	0.00143	CcSEcCtD
Morphine—Body temperature increased—Ezetimibe—atherosclerosis	0.000187	0.00143	CcSEcCtD
Morphine—Paraesthesia—Niacin—atherosclerosis	0.000186	0.00142	CcSEcCtD
Morphine—Feeling abnormal—Simvastatin—atherosclerosis	0.000186	0.00142	CcSEcCtD
Morphine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000186	0.00142	CcSEcCtD
Morphine—Dyspnoea—Niacin—atherosclerosis	0.000185	0.00141	CcSEcCtD
Morphine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000185	0.00141	CcSEcCtD
Morphine—Insomnia—Pravastatin—atherosclerosis	0.000185	0.00141	CcSEcCtD
Morphine—Somnolence—Niacin—atherosclerosis	0.000184	0.00141	CcSEcCtD
Morphine—Naloxone—ALB—atherosclerosis	0.000183	0.0888	CrCbGaD
Morphine—Paraesthesia—Pravastatin—atherosclerosis	0.000183	0.0014	CcSEcCtD
Morphine—Dyspepsia—Niacin—atherosclerosis	0.000182	0.00139	CcSEcCtD
Morphine—Dyspnoea—Pravastatin—atherosclerosis	0.000182	0.00139	CcSEcCtD
Morphine—Decreased appetite—Niacin—atherosclerosis	0.00018	0.00137	CcSEcCtD
Morphine—Dyspepsia—Pravastatin—atherosclerosis	0.00018	0.00137	CcSEcCtD
Morphine—Rash—Rosuvastatin—atherosclerosis	0.00018	0.00137	CcSEcCtD
Morphine—Dermatitis—Rosuvastatin—atherosclerosis	0.000179	0.00137	CcSEcCtD
Morphine—Urticaria—Simvastatin—atherosclerosis	0.000179	0.00137	CcSEcCtD
Morphine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000179	0.00137	CcSEcCtD
Morphine—Body temperature increased—Simvastatin—atherosclerosis	0.000178	0.00136	CcSEcCtD
Morphine—Abdominal pain—Simvastatin—atherosclerosis	0.000178	0.00136	CcSEcCtD
Morphine—Headache—Rosuvastatin—atherosclerosis	0.000178	0.00136	CcSEcCtD
Morphine—Hypersensitivity—Lovastatin—atherosclerosis	0.000178	0.00136	CcSEcCtD
Morphine—Decreased appetite—Pravastatin—atherosclerosis	0.000177	0.00135	CcSEcCtD
Morphine—Pain—Niacin—atherosclerosis	0.000177	0.00135	CcSEcCtD
Morphine—Fatigue—Pravastatin—atherosclerosis	0.000176	0.00134	CcSEcCtD
Morphine—Constipation—Pravastatin—atherosclerosis	0.000175	0.00133	CcSEcCtD
Morphine—Pain—Pravastatin—atherosclerosis	0.000175	0.00133	CcSEcCtD
Morphine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000174	0.00133	CcSEcCtD
Morphine—Asthenia—Lovastatin—atherosclerosis	0.000173	0.00132	CcSEcCtD
Morphine—Pruritus—Lovastatin—atherosclerosis	0.000171	0.0013	CcSEcCtD
Morphine—Asthenia—Ezetimibe—atherosclerosis	0.00017	0.0013	CcSEcCtD
Morphine—Gastrointestinal pain—Niacin—atherosclerosis	0.00017	0.00129	CcSEcCtD
Morphine—Nausea—Rosuvastatin—atherosclerosis	0.000169	0.00129	CcSEcCtD
Morphine—Feeling abnormal—Pravastatin—atherosclerosis	0.000168	0.00128	CcSEcCtD
Morphine—Pruritus—Ezetimibe—atherosclerosis	0.000167	0.00128	CcSEcCtD
Morphine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000167	0.00127	CcSEcCtD
Morphine—Hypersensitivity—Simvastatin—atherosclerosis	0.000166	0.00127	CcSEcCtD
Morphine—Diarrhoea—Lovastatin—atherosclerosis	0.000165	0.00126	CcSEcCtD
Morphine—Urticaria—Niacin—atherosclerosis	0.000165	0.00126	CcSEcCtD
Morphine—Abdominal pain—Niacin—atherosclerosis	0.000164	0.00125	CcSEcCtD
Morphine—Body temperature increased—Niacin—atherosclerosis	0.000164	0.00125	CcSEcCtD
Morphine—Urticaria—Pravastatin—atherosclerosis	0.000162	0.00124	CcSEcCtD
Morphine—Asthenia—Simvastatin—atherosclerosis	0.000162	0.00124	CcSEcCtD
Morphine—Diarrhoea—Ezetimibe—atherosclerosis	0.000162	0.00124	CcSEcCtD
Morphine—Abdominal pain—Pravastatin—atherosclerosis	0.000161	0.00123	CcSEcCtD
Morphine—Body temperature increased—Pravastatin—atherosclerosis	0.000161	0.00123	CcSEcCtD
Morphine—Pruritus—Simvastatin—atherosclerosis	0.00016	0.00122	CcSEcCtD
Morphine—Dizziness—Lovastatin—atherosclerosis	0.00016	0.00122	CcSEcCtD
Morphine—Dizziness—Ezetimibe—atherosclerosis	0.000157	0.00119	CcSEcCtD
Morphine—Diarrhoea—Simvastatin—atherosclerosis	0.000154	0.00118	CcSEcCtD
Morphine—Vomiting—Lovastatin—atherosclerosis	0.000153	0.00117	CcSEcCtD
Morphine—Hypersensitivity—Niacin—atherosclerosis	0.000153	0.00116	CcSEcCtD
Morphine—Rash—Lovastatin—atherosclerosis	0.000152	0.00116	CcSEcCtD
Morphine—Dermatitis—Lovastatin—atherosclerosis	0.000152	0.00116	CcSEcCtD
Morphine—Headache—Lovastatin—atherosclerosis	0.000151	0.00115	CcSEcCtD
Morphine—Vomiting—Ezetimibe—atherosclerosis	0.000151	0.00115	CcSEcCtD
Morphine—Hypersensitivity—Pravastatin—atherosclerosis	0.00015	0.00115	CcSEcCtD
Morphine—Dizziness—Simvastatin—atherosclerosis	0.000149	0.00114	CcSEcCtD
Morphine—Rash—Ezetimibe—atherosclerosis	0.000149	0.00114	CcSEcCtD
Morphine—Dermatitis—Ezetimibe—atherosclerosis	0.000149	0.00114	CcSEcCtD
Morphine—Asthenia—Niacin—atherosclerosis	0.000149	0.00113	CcSEcCtD
Morphine—Headache—Ezetimibe—atherosclerosis	0.000148	0.00113	CcSEcCtD
Morphine—Pruritus—Niacin—atherosclerosis	0.000147	0.00112	CcSEcCtD
Morphine—Asthenia—Pravastatin—atherosclerosis	0.000146	0.00112	CcSEcCtD
Morphine—Pruritus—Pravastatin—atherosclerosis	0.000144	0.0011	CcSEcCtD
Morphine—Vomiting—Simvastatin—atherosclerosis	0.000144	0.00109	CcSEcCtD
Morphine—Nausea—Lovastatin—atherosclerosis	0.000143	0.00109	CcSEcCtD
Morphine—Rash—Simvastatin—atherosclerosis	0.000142	0.00109	CcSEcCtD
Morphine—Dermatitis—Simvastatin—atherosclerosis	0.000142	0.00108	CcSEcCtD
Morphine—Diarrhoea—Niacin—atherosclerosis	0.000142	0.00108	CcSEcCtD
Morphine—Headache—Simvastatin—atherosclerosis	0.000141	0.00108	CcSEcCtD
Morphine—Nausea—Ezetimibe—atherosclerosis	0.000141	0.00107	CcSEcCtD
Morphine—Diarrhoea—Pravastatin—atherosclerosis	0.00014	0.00107	CcSEcCtD
Morphine—Dizziness—Niacin—atherosclerosis	0.000137	0.00105	CcSEcCtD
Morphine—Dizziness—Pravastatin—atherosclerosis	0.000135	0.00103	CcSEcCtD
Morphine—Nausea—Simvastatin—atherosclerosis	0.000134	0.00102	CcSEcCtD
Morphine—Vomiting—Niacin—atherosclerosis	0.000132	0.00101	CcSEcCtD
Morphine—Rash—Niacin—atherosclerosis	0.000131	0.000997	CcSEcCtD
Morphine—Dermatitis—Niacin—atherosclerosis	0.000131	0.000996	CcSEcCtD
Morphine—Headache—Niacin—atherosclerosis	0.00013	0.000991	CcSEcCtD
Morphine—Vomiting—Pravastatin—atherosclerosis	0.00013	0.00099	CcSEcCtD
Morphine—Rash—Pravastatin—atherosclerosis	0.000129	0.000982	CcSEcCtD
Morphine—Dermatitis—Pravastatin—atherosclerosis	0.000129	0.000981	CcSEcCtD
Morphine—Headache—Pravastatin—atherosclerosis	0.000128	0.000975	CcSEcCtD
Morphine—Nausea—Niacin—atherosclerosis	0.000123	0.000939	CcSEcCtD
Morphine—Nausea—Pravastatin—atherosclerosis	0.000121	0.000925	CcSEcCtD
Morphine—UGT1A8—Metabolism—AKT1—atherosclerosis	8.94e-06	0.000106	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LPA—atherosclerosis	8.93e-06	0.000106	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP3—atherosclerosis	8.88e-06	0.000105	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARA—atherosclerosis	8.85e-06	0.000105	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ESR1—atherosclerosis	8.85e-06	0.000105	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF2—atherosclerosis	8.84e-06	0.000105	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—INS—atherosclerosis	8.83e-06	0.000105	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	8.75e-06	0.000104	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—F2—atherosclerosis	8.74e-06	0.000104	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NAMPT—atherosclerosis	8.7e-06	0.000103	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.67e-06	0.000103	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—BGN—atherosclerosis	8.65e-06	0.000103	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.65e-06	0.000103	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—LIPC—atherosclerosis	8.64e-06	0.000103	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOC3—atherosclerosis	8.59e-06	0.000102	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APOB—atherosclerosis	8.58e-06	0.000102	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AGT—atherosclerosis	8.57e-06	0.000102	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOA5—atherosclerosis	8.56e-06	0.000102	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—LDLR—atherosclerosis	8.54e-06	0.000101	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	8.51e-06	0.000101	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	8.49e-06	0.000101	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALOX5—atherosclerosis	8.45e-06	0.0001	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EDN1—atherosclerosis	8.44e-06	0.0001	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—APOE—atherosclerosis	8.4e-06	9.97e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL5—atherosclerosis	8.38e-06	9.94e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	8.36e-06	9.92e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CETP—atherosclerosis	8.34e-06	9.9e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—atherosclerosis	8.33e-06	9.88e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CAV1—atherosclerosis	8.32e-06	9.87e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—APOA1—atherosclerosis	8.3e-06	9.85e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AGT—atherosclerosis	8.29e-06	9.84e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	8.24e-06	9.78e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—LPL—atherosclerosis	8.19e-06	9.72e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.13e-06	9.65e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APOE—atherosclerosis	8.12e-06	9.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—LEP—atherosclerosis	8.12e-06	9.64e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL6—atherosclerosis	8.1e-06	9.62e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ALB—atherosclerosis	8.09e-06	9.61e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CAV1—atherosclerosis	8.05e-06	9.55e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APOA1—atherosclerosis	8.03e-06	9.53e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	8.01e-06	9.5e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SCARB1—atherosclerosis	7.99e-06	9.48e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	7.96e-06	9.45e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALOX5—atherosclerosis	7.96e-06	9.45e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—INS—atherosclerosis	7.92e-06	9.39e-05	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—atherosclerosis	7.81e-06	9.27e-05	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—atherosclerosis	7.81e-06	9.27e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCL2—atherosclerosis	7.79e-06	9.24e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.78e-06	9.23e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SPP1—atherosclerosis	7.76e-06	9.21e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ESR1—atherosclerosis	7.76e-06	9.21e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—NOS3—atherosclerosis	7.74e-06	9.19e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	7.72e-06	9.17e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCG1—atherosclerosis	7.71e-06	9.15e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—F2—atherosclerosis	7.66e-06	9.09e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1—atherosclerosis	7.66e-06	9.09e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CG—atherosclerosis	7.58e-06	8.99e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NAMPT—atherosclerosis	7.58e-06	8.99e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HMGCR—atherosclerosis	7.54e-06	8.95e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LIPC—atherosclerosis	7.53e-06	8.94e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOC3—atherosclerosis	7.48e-06	8.88e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—atherosclerosis	7.47e-06	8.87e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LDLR—atherosclerosis	7.44e-06	8.83e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	7.33e-06	8.7e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARG—atherosclerosis	7.31e-06	8.68e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	7.27e-06	8.63e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CETP—atherosclerosis	7.27e-06	8.62e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—FABP4—atherosclerosis	7.25e-06	8.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LCAT—atherosclerosis	7.25e-06	8.6e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	7.18e-06	8.52e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—INS—atherosclerosis	7.17e-06	8.51e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NAMPT—atherosclerosis	7.14e-06	8.48e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.13e-06	8.47e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOA4—atherosclerosis	7.11e-06	8.44e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LIPC—atherosclerosis	7.1e-06	8.42e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—atherosclerosis	7.08e-06	8.4e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOC3—atherosclerosis	7.05e-06	8.37e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	7.02e-06	8.33e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LDLR—atherosclerosis	7.01e-06	8.32e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGT—atherosclerosis	7.01e-06	8.32e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	6.99e-06	8.29e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SCARB1—atherosclerosis	6.96e-06	8.26e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOS3—atherosclerosis	6.94e-06	8.24e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—INS—atherosclerosis	6.94e-06	8.24e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—LEP—atherosclerosis	6.87e-06	8.15e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APOE—atherosclerosis	6.87e-06	8.15e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CETP—atherosclerosis	6.85e-06	8.13e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL2—atherosclerosis	6.83e-06	8.1e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.8e-06	8.07e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CAV1—atherosclerosis	6.8e-06	8.07e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APOA1—atherosclerosis	6.79e-06	8.06e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCA1—atherosclerosis	6.72e-06	7.98e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1—atherosclerosis	6.71e-06	7.97e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALB—atherosclerosis	6.58e-06	7.81e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HMGCR—atherosclerosis	6.57e-06	7.8e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SCARB1—atherosclerosis	6.56e-06	7.78e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ESR1—atherosclerosis	6.56e-06	7.78e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—F2—atherosclerosis	6.48e-06	7.69e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	6.46e-06	7.67e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.44e-06	7.65e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	6.38e-06	7.57e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NOS3—atherosclerosis	6.29e-06	7.47e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	6.2e-06	7.35e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HMGCR—atherosclerosis	6.19e-06	7.35e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	6.16e-06	7.31e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.12e-06	7.27e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.12e-06	7.27e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.12e-06	7.27e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOA2—atherosclerosis	6.12e-06	7.27e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOS3—atherosclerosis	6.09e-06	7.22e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.05e-06	7.18e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	5.95e-06	7.06e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	5.93e-06	7.04e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—INS—atherosclerosis	5.87e-06	6.96e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ABCA1—atherosclerosis	5.86e-06	6.95e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—atherosclerosis	5.85e-06	6.95e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LPA—atherosclerosis	5.84e-06	6.93e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL2—atherosclerosis	5.77e-06	6.85e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HMOX1—atherosclerosis	5.77e-06	6.85e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—atherosclerosis	5.75e-06	6.83e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—atherosclerosis	5.67e-06	6.73e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BGN—atherosclerosis	5.66e-06	6.71e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOA5—atherosclerosis	5.6e-06	6.65e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—atherosclerosis	5.57e-06	6.61e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOB—atherosclerosis	5.52e-06	6.56e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCA1—atherosclerosis	5.52e-06	6.55e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	5.51e-06	6.54e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	5.42e-06	6.43e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	5.4e-06	6.41e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	5.4e-06	6.41e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.39e-06	6.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	5.39e-06	6.39e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—atherosclerosis	5.37e-06	6.38e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—LPL—atherosclerosis	5.28e-06	6.26e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	5.22e-06	6.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.21e-06	6.18e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GPX1—atherosclerosis	5.15e-06	6.11e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOS3—atherosclerosis	5.14e-06	6.11e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—atherosclerosis	5.13e-06	6.09e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HMOX1—atherosclerosis	5.02e-06	5.96e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CD36—atherosclerosis	5.01e-06	5.95e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	5e-06	5.94e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—atherosclerosis	4.95e-06	5.88e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—atherosclerosis	4.88e-06	5.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	4.83e-06	5.73e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOB—atherosclerosis	4.81e-06	5.71e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.75e-06	5.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	4.75e-06	5.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	4.74e-06	5.62e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HMOX1—atherosclerosis	4.73e-06	5.62e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	4.73e-06	5.61e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—atherosclerosis	4.68e-06	5.56e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.67e-06	5.54e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARA—atherosclerosis	4.66e-06	5.53e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LIPC—atherosclerosis	4.64e-06	5.51e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOC3—atherosclerosis	4.61e-06	5.47e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—LPL—atherosclerosis	4.6e-06	5.45e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	4.59e-06	5.45e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LDLR—atherosclerosis	4.58e-06	5.44e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	4.56e-06	5.42e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOB—atherosclerosis	4.54e-06	5.38e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AGT—atherosclerosis	4.51e-06	5.36e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GPX1—atherosclerosis	4.48e-06	5.32e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CETP—atherosclerosis	4.48e-06	5.31e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOE—atherosclerosis	4.42e-06	5.25e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.41e-06	5.24e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	4.41e-06	5.23e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	4.38e-06	5.2e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CAV1—atherosclerosis	4.38e-06	5.2e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOA1—atherosclerosis	4.37e-06	5.19e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CD36—atherosclerosis	4.37e-06	5.18e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—atherosclerosis	4.34e-06	5.15e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—atherosclerosis	4.34e-06	5.15e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—LPL—atherosclerosis	4.33e-06	5.14e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.29e-06	5.09e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GPX1—atherosclerosis	4.23e-06	5.01e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—atherosclerosis	4.19e-06	4.97e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	4.15e-06	4.92e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTHFR—atherosclerosis	4.14e-06	4.91e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—atherosclerosis	4.13e-06	4.9e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CD36—atherosclerosis	4.11e-06	4.88e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	4.08e-06	4.85e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARA—atherosclerosis	4.06e-06	4.82e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.05e-06	4.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	4.02e-06	4.78e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	4.01e-06	4.76e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	4e-06	4.75e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.99e-06	4.74e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AGT—atherosclerosis	3.93e-06	4.67e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.9e-06	4.63e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOE—atherosclerosis	3.85e-06	4.57e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—atherosclerosis	3.85e-06	4.57e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARA—atherosclerosis	3.83e-06	4.54e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CAV1—atherosclerosis	3.82e-06	4.53e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOA1—atherosclerosis	3.81e-06	4.52e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—INS—atherosclerosis	3.78e-06	4.48e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	3.71e-06	4.4e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AGT—atherosclerosis	3.7e-06	4.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—atherosclerosis	3.67e-06	4.36e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOE—atherosclerosis	3.63e-06	4.31e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.61e-06	4.28e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.6e-06	4.27e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.59e-06	4.26e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—atherosclerosis	3.56e-06	4.22e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	3.51e-06	4.16e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.48e-06	4.13e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—atherosclerosis	3.46e-06	4.11e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—atherosclerosis	3.46e-06	4.1e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	3.4e-06	4.04e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—atherosclerosis	3.36e-06	3.98e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NOS3—atherosclerosis	3.31e-06	3.93e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—INS—atherosclerosis	3.29e-06	3.91e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.28e-06	3.89e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—atherosclerosis	3.19e-06	3.79e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.16e-06	3.75e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—INS—atherosclerosis	3.1e-06	3.68e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.1e-06	3.67e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—atherosclerosis	3.03e-06	3.6e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.03e-06	3.6e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—atherosclerosis	3.02e-06	3.58e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOB—atherosclerosis	2.97e-06	3.52e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—atherosclerosis	2.89e-06	3.43e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NOS3—atherosclerosis	2.89e-06	3.43e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.88e-06	3.42e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—atherosclerosis	2.84e-06	3.37e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—LPL—atherosclerosis	2.83e-06	3.36e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—atherosclerosis	2.8e-06	3.32e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.76e-06	3.28e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.72e-06	3.23e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CD36—atherosclerosis	2.69e-06	3.19e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.64e-06	3.13e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—atherosclerosis	2.56e-06	3.04e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.55e-06	3.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.5e-06	2.97e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.49e-06	2.95e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AGT—atherosclerosis	2.42e-06	2.87e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOE—atherosclerosis	2.37e-06	2.82e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—atherosclerosis	2.36e-06	2.81e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.35e-06	2.79e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.35e-06	2.78e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.14e-06	2.54e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.07e-06	2.45e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—INS—atherosclerosis	2.03e-06	2.41e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—atherosclerosis	1.86e-06	2.21e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.78e-06	2.11e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.63e-06	1.93e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.52e-06	1.81e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—atherosclerosis	1.33e-06	1.57e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.25e-06	1.48e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—atherosclerosis	8.17e-07	9.7e-06	CbGpPWpGaD
